Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non–ST-segment elevation acute myocardial infarction (the ARMADA study)-Reference-Cited by-同舟云学术

Comparison of effects on markers of blood cell activation of enoxaparin, dalteparin, and unfractionated heparin in patients with unstable angina pectoris or non–ST-segment elevation acute myocardial infarction (the ARMADA study)

Published:2003-04 Issue:8 Volume:91 Page:925-930
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Montalescot Gilles,Bal-dit-Sollier Claire,Chibedi Daniela,Collet Jean-Philippe,Soulat Thierry,Dalby Miles,Choussat R.émi,Cohen Ariel,Slama Michel,Steg Phillipe Gabriel,Dubois-Randé Jean-Luc,Metzger Jean-Philippe,Tarragano François,Guermonprez Jean L,Drouet Ludovic

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group;Cohen;N Engl J Med,1997

2. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the Thrombolysis In Myocardial Infarction (TIMI) 11B trial;Antman;Circulation,1999

3. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC);Klein;Circulation,1997

4. Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease;Montalescot;Circulation,1998

5. Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina;Montalescot;J Am Coll Cardiol,2000

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular disease and thrombosis: Intersections with the immune system, inflammation, and the coagulation system;Annales Pharmaceutiques Françaises;2024-08

2. Mean Activated Clotting Time of Patients Receiving Intravenous Heparin and Undergoing Primary Percutaneous Coronary Intervention for ST Elevation Myocardial Infarction;Cureus;2024-03-25

3. In-stent Thrombosis and COVID-19 Infection: Current Insights on the Mechanistic Relationship;Current Cardiology Reviews;2023-01

4. What is the role of Von Willebrand factor in chronic hepatitis B virus infection to hepatocellular carcinoma: a review article;Therapeutic Advances in Chronic Disease;2022-01

5. Impact of low molecular weight heparin administration on the clinical course of the COVID-19 disease;TURKISH JOURNAL OF MEDICAL SCIENCES;2021-02-26